Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001
To the Editor: Dr Frazier and colleagues1 present a timely cost-effectiveness analysis of methods for screening the general population to decrease morality from colorectal cancer. Although colonoscopy, the most sensitive test, is currently the most expensive, costs could decrease dramatically if the procedure were performed by trained, nonphysician technicians under the supervision of a gastroenterologist. The gastroenterologist could supervise a number of technicians simultaneously while personally visualizing suspicious lesions and performing biopsies when appropriate.
Donohoe M. Cost-effectiveness of Colorectal Cancer Screening. JAMA. 2001;285(4):407-408. doi:10.1001/jama.285.4.407